A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgery
Titel:
A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgery
Auteur:
Vergote, I. Oaknin, A. Baurain, J.-F. Ananda, S. Wong, S. Su, X. Wu, B. Zhong, Z. Warner, D. Casado, A.